These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
261 related items for PubMed ID: 14738882
1. DSCR1 gene expression is dependent on NFATc1 during cardiac valve formation and colocalizes with anomalous organ development in trisomy 16 mice. Lange AW, Molkentin JD, Yutzey KE. Dev Biol; 2004 Feb 15; 266(2):346-60. PubMed ID: 14738882 [Abstract] [Full Text] [Related]
2. Restoration of DSCR1 to disomy in the trisomy 16 mouse model of Down syndrome does not correct cardiac or craniofacial development anomalies. Lange AW, Rothermel BA, Yutzey KE. Dev Dyn; 2005 Jul 15; 233(3):954-63. PubMed ID: 15906378 [Abstract] [Full Text] [Related]
4. Characterization of Nfatc1 regulation identifies an enhancer required for gene expression that is specific to pro-valve endocardial cells in the developing heart. Zhou B, Wu B, Tompkins KL, Boyer KL, Grindley JC, Baldwin HS. Development; 2005 Mar 15; 132(5):1137-46. PubMed ID: 15689382 [Abstract] [Full Text] [Related]
6. NFATc1 expression in the developing heart valves is responsive to the RANKL pathway and is required for endocardial expression of cathepsin K. Lange AW, Yutzey KE. Dev Biol; 2006 Apr 15; 292(2):407-17. PubMed ID: 16680826 [Abstract] [Full Text] [Related]
7. Sculpting heart valves with NFATc and VEGF. Lambrechts D, Carmeliet P. Cell; 2004 Sep 03; 118(5):532-4. PubMed ID: 15339657 [Abstract] [Full Text] [Related]
8. DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Fuentes JJ, Genescà L, Kingsbury TJ, Cunningham KW, Pérez-Riba M, Estivill X, de la Luna S. Hum Mol Genet; 2000 Jul 01; 9(11):1681-90. PubMed ID: 10861295 [Abstract] [Full Text] [Related]
10. Trisomy of the Dscr1 gene suppresses early progression of pancreatic intraepithelial neoplasia driven by oncogenic Kras. Lee JC, Shin J, Baek KH. Biochem Biophys Res Commun; 2013 Oct 11; 440(1):50-5. PubMed ID: 24041692 [Abstract] [Full Text] [Related]
11. The secondary heart field is a new site of calcineurin/Nfatc1 signaling for semilunar valve development. Lin CY, Lin CJ, Chen CH, Chen RM, Zhou B, Chang CP. J Mol Cell Cardiol; 2012 May 11; 52(5):1096-102. PubMed ID: 22300732 [Abstract] [Full Text] [Related]
13. VEGF selectively induces Down syndrome critical region 1 gene expression in endothelial cells: a mechanism for feedback regulation of angiogenesis? Yao YG, Duh EJ. Biochem Biophys Res Commun; 2004 Aug 27; 321(3):648-56. PubMed ID: 15358155 [Abstract] [Full Text] [Related]
15. Depolarization of neural cells induces transcription of the Down syndrome critical region 1 isoform 4 via a calcineurin/nuclear factor of activated T cells-dependent pathway. Cano E, Canellada A, Minami T, Iglesias T, Redondo JM. J Biol Chem; 2005 Aug 19; 280(33):29435-43. PubMed ID: 15975916 [Abstract] [Full Text] [Related]
16. A single extra copy of Dscr1 improves survival of mice developing spontaneous lung tumors through suppression of tumor angiogenesis. Shin J, Lee JC, Baek KH. Cancer Lett; 2014 Jan 01; 342(1):70-81. PubMed ID: 24051307 [Abstract] [Full Text] [Related]
17. DSCR1 (ADAPT78) lethality: evidence for a protective effect of trisomy 21 genes? Kluetzman KS, Perez AV, Crawford DR. Biochem Biophys Res Commun; 2005 Nov 18; 337(2):595-601. PubMed ID: 16198305 [Abstract] [Full Text] [Related]